BioNano Genomics Inc. WT EXP 082123

Company Profile

BioNano Genomics Inc. WT EXP 082123 had its IPO on 2018-09-21 under the ticker symbol BNGOW.

The company operates in the Other sector and Other industry. BioNano Genomics Inc. WT EXP 082123 has a staff strength of 0 employees.

Stock update

Shares of BioNano Genomics Inc. WT EXP 082123 opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a -23.4% slip from the previous day's closing price.

A total volume of 63,789 shares were traded at the close of the day’s session.

In the last one week, shares of BioNano Genomics Inc. WT EXP 082123 have slipped by -64%.

BioNano Genomics Inc. WT EXP 082123's Key Ratios

BioNano Genomics Inc. WT EXP 082123 has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months BioNano Genomics Inc. WT EXP 082123’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures BioNano Genomics Inc. WT EXP 082123's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BioNano Genomics Inc. WT EXP 082123’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, BioNano Genomics Inc. WT EXP 082123’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BioNano Genomics Inc. WT EXP 082123’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BioNano Genomics Inc. WT EXP 082123’s profitability.

BioNano Genomics Inc. WT EXP 082123 stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

BioNano Genomics Inc. WT EXP 082123 stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$292.15 million

Total Liabilities

$38.14 million

Operating Cash Flow

$0

Capital Expenditure

$360000

Dividend Payout Ratio

0%

BioNano Genomics Inc. WT EXP 082123 ended 2024 with $292.15 million in total assets and $0 in total liabilities. Its intangible assets were valued at $292.15 million while shareholder equity stood at $231.49 million.

BioNano Genomics Inc. WT EXP 082123 ended 2024 with $0 in deferred long-term liabilities, $38.14 million in other current liabilities, 31000.00 in common stock, $-385839000.00 in retained earnings and $77.29 million in goodwill. Its cash balance stood at $4.10 million and cash and short-term investments were $95.81 million. The company’s total short-term debt was $2,517,000 while long-term debt stood at $0.

BioNano Genomics Inc. WT EXP 082123’s total current assets stands at $142.56 million while long-term investments were $0 and short-term investments were $91.70 million. Its net receivables were $6.78 million compared to accounts payable of $15.78 million and inventory worth $33.11 million.

In 2024, BioNano Genomics Inc. WT EXP 082123's operating cash flow was $0 while its capital expenditure stood at $360000.

Comparatively, BioNano Genomics Inc. WT EXP 082123 paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0

52-Week High

$0.841

52-Week Low

$0.0301

Analyst Target Price

$

BioNano Genomics Inc. WT EXP 082123 stock is currently trading at $0 per share. It touched a 52-week high of $0.841 and a 52-week low of $0.841. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.02 and 200-day moving average was $0.14 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.